We next analyzed the percentages of CD4+ IL-17F-expressing cells in CLL (n = 12) and healthy (n = 5) PBMCs activated in vitro by TCR cross-linking. The gene discussed is CD4; the disease is B-cell chronic lymphocytic leukemia.